New cancer drug shows promise in early trial for advanced tumors
Disease control
Recruiting now
This study is testing a new drug called NUC-7738 in people with advanced solid tumors or lymphoma that have not responded to other treatments. The goal is to find a safe dose and see if the drug can shrink tumors, either alone or combined with another drug (pembrolizumab). About …
Phase: PHASE1, PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated May 17, 2026 05:37 UTC